121 related articles for article (PubMed ID: 31910706)
21. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
22. The role of DNA methylation in catechol-enhanced erythroid differentiation of K562 cells.
Li XF; Wu XR; Xue M; Wang Y; Wang J; Li Y; Suriguga ; Zhang GY; Yi ZC
Toxicol Appl Pharmacol; 2012 Nov; 265(1):43-50. PubMed ID: 23022512
[TBL] [Abstract][Full Text] [Related]
23. microRNA-196a Overexpression Inhibits Apoptosis in Hemin-Induced K562 Cells.
Zhao X; Liu Z; Shen J; Yong L; Xia Y; Bian M
DNA Cell Biol; 2020 Feb; 39(2):235-243. PubMed ID: 31913716
[TBL] [Abstract][Full Text] [Related]
24. Quantitative proteomics reveals that miR-222 inhibits erythroid differentiation by targeting BLVRA and CRKL.
Jiang L; Wang X; Wang Y; Chen X
Cell Biochem Funct; 2018 Mar; 36(2):95-105. PubMed ID: 29368338
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial cells and smooth muscle cells mediate carbachol-induced hepatocyte proliferation via muscarinic receptors and IP3/PKC signaling cascades.
Yoshimura R; Arai J; Endo Y
Cell Biol Int; 2009 Apr; 33(4):516-23. PubMed ID: 19353780
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
27. The role of ROS in hydroquinone-induced inhibition of K562 cell erythroid differentiation.
Yu CH; Suriguga ; Li Y; Li YR; Tang KY; Jiang L; Yi ZC
Biomed Environ Sci; 2014 Mar; 27(3):212-4. PubMed ID: 24709103
[TBL] [Abstract][Full Text] [Related]
28. The role of GATA switch in benzene metabolite hydroquinone inhibiting erythroid differentiation in K562 cells.
Yu CH; Yang SQ; Zhang YJ; Rong L; Yi ZC
Arch Toxicol; 2023 Aug; 97(8):2169-2181. PubMed ID: 37329354
[TBL] [Abstract][Full Text] [Related]
29. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
30. SIRT1 is a critical regulator of K562 cell growth, survival, and differentiation.
Duncan MT; DeLuca TA; Kuo HY; Yi M; Mrksich M; Miller WM
Exp Cell Res; 2016 May; 344(1):40-52. PubMed ID: 27086164
[TBL] [Abstract][Full Text] [Related]
31. Anti-H can trigger apoptosis and down-regulate FUT1 expression in erythroid differentiated K562 cells without complement mediation.
Zhou H; Yu Y; Li H; Shi W; Yang H; Liu C; Wang S; Yu M
Transpl Immunol; 2012 Dec; 27(4):151-6. PubMed ID: 23063462
[TBL] [Abstract][Full Text] [Related]
32. miR-451 enhances erythroid differentiation in K562 cells.
Bruchova-Votavova H; Yoon D; Prchal JT
Leuk Lymphoma; 2010 Apr; 51(4):686-93. PubMed ID: 20218812
[TBL] [Abstract][Full Text] [Related]
33. Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells.
Wu XR; Xue M; Li XF; Wang Y; Wang J; Han QL; Yi ZC
Toxicol Lett; 2011 Jun; 203(3):190-9. PubMed ID: 21414390
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy.
Yan HW; Hu WX; Zhang JY; Wang Y; Xia K; Peng MY; Liu J
Tumour Biol; 2014 Jun; 35(6):5381-8. PubMed ID: 24526417
[TBL] [Abstract][Full Text] [Related]
35. C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.
Brognara E; Lampronti I; Breveglieri G; Accetta A; Corradini R; Manicardi A; Borgatti M; Canella A; Multineddu C; Marchelli R; Gambari R
Eur J Pharmacol; 2011 Dec; 672(1-3):30-7. PubMed ID: 21958870
[TBL] [Abstract][Full Text] [Related]
36. Enhancement by retinoid of hemin-induced differentiation of human leukemia K562 cell line.
Nakajima O; Hashimoto Y; Iwasaki S
FEBS Lett; 1993 Sep; 330(1):81-4. PubMed ID: 8370465
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
38. Saracatinib prompts hemin-induced K562 erythroid differentiation but suppresses erythropoiesis of hematopoietic stem cells.
Ding L; Chen D; Li Y; Xie Y; Sun X; Wang D
Hum Cell; 2024 May; 37(3):648-665. PubMed ID: 38388899
[TBL] [Abstract][Full Text] [Related]
39. Protein phosphatase 2A regulatory subunit B56β modulates erythroid differentiation.
Wu J; Wang J; Zeng X; Chen Y; Xia J; Wang S; Huang Z; Chen W; Shen Z
Biochem Biophys Res Commun; 2016 Sep; 478(3):1179-84. PubMed ID: 27544028
[TBL] [Abstract][Full Text] [Related]
40. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
